Soleno Therapeutics (SLNO) Q2 2025 Earnings

May 7Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.83
-1.41
-0.99
-0.57

Details

Expected EPS
-0.97
Actual EPS
-0.95
Surprise EPS
0.02
Surprise Percent
+2.06%

Description

⁨Soleno Therapeutics⁩ (⁦SLNO⁩) has reported earnings of ⁦-0.95⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts